Sean P. Nolan Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Sean P. Nolan.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Sean P. Nolan. Sean P. Nolan is a Director in Ventas, Inc. ($VTR) and a Director in AQUINOX PHARMACEUTICALS, INC ($AQXP) and a President & CEO in AveXis, Inc. ($AVXS) and a Director in Taysha Gene Therapies, Inc. ($TSHA).
Address: C/O INTERMUNE, INC. 3280 BAYSHORE BOULEVARD BRISBANE 94005 CA
Companies in which Sean P. Nolan is an Insider
AveXis, Inc.
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Sean P. Nolan: President & CEO
Holdings: 0 shares
Current Value: $0
Latest Transaction: May 15 2018
$AVXS Market Capitalization: $1.59B
$AVXS Previous Close: $58.95
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Neoleukin Therapeutics, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Sean P. Nolan: Director
Holdings: 0 shares
Current Value: $0
Latest Transaction: May 07 2020
$NLTX Market Capitalization: $451.60M
$NLTX Previous Close: $18.81
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Taysha Gene Therapies, Inc.
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Sean P. Nolan: Director
Holdings: 1,089,500 shares
Latest Transaction: Sep 30 2020
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Ventas, Inc.
Industry: REAL ESTATE INVESTMENT TRUSTS [6798]
Position of Sean P. Nolan: Director
Holdings: 7,555 shares
Current Value: $466,975
Latest Transaction: May 20 2020
$VTR Market Capitalization: $22.04B
$VTR Previous Close: $61.81
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of Sean P. Nolan
Sentiment: All, AVXS, NLTX, TSHA, VTR
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sep 30 2020 | TSHA | Taysha Gene Therap ... | Nolan Sean P. | Director | Option Exercise | C | 0.00 | 1,470 | 0 | 0 | |
| Sep 30 2020 | TSHA | Taysha Gene Therap ... | Nolan Sean P. | Director | Option Exercise | C | 0.00 | 1,000,000 | 0 | 0 | |
| Sep 30 2020 | TSHA | Taysha Gene Therap ... | Nolan Sean P. | Director | Buy | C | 0.00 | 1,601 | 0 | 1,091,101 | 1.1 M to 1.1 M (+0.15 %) |
| Sep 30 2020 | TSHA | Taysha Gene Therap ... | Nolan Sean P. | Director | Buy | C | 0.00 | 1,089,500 | 0 | 1,089,500 | 0 to 1.1 M |
| Sep 25 2020 | TSHA | Taysha Gene Therap ... | Nolan Sean P. | Director | Option Exercise | A | 20.00 | 31,000 | 620,000 | 31,000 | |
| May 20 2020 | VTR | Ventas, Inc. | Nolan Sean P. | Director | Grant | A | 0.00 | 5,424 | 0 | 7,555 | 2.1 K to 7.6 K (+254.53 %) |
| May 20 2020 | VTR | Ventas, Inc. | Nolan Sean P. | Director | Grant | A | 0.00 | 5,424 | 0 | 7,555 | 2.1 K to 7.6 K (+254.53 %) |